US regulator approves teplizumab which can delay the onset of Type 1 diabetes

FDA Approves First Drug That 'Can Delay' Stage 3 Type 1 Diabetes

The U.S. Food and Drug Administration (FDA) announced Thursday it approved a new drug that “can delay” the onset of stage 3 type 1 diabetes, which is the symptomatic stage of type 1 diabetes. The drug, teplizumab-mzwv, is to be used to delay the onset of stage 3 type 1 diabetes in adults and pediatric patients 8 years and older, who currently have stage 2 type 1 diabetes, the FDA announced. Made by Provention Bio, in partnership with Sanofi, the…

FDA approves 1st drug to delay onset of Type 1 diabetes

For the first time, the U.S. Food and Drug Administration on Thursday approved a treatment that can delay the onset of Type 1 diabetes.

FDA Approves First Drug to Delay Onset of Type 1 Diabetes

FRIDAY, Nov. 18, 2022 (HealthDay News) -- The U.S. Food and Drug Administration on Thursday approved the first drug that could delay the development of stage 3 type 1 diabetes

FDA OKs Treatment to Delay Insulin-Dependent Type 1 Diabetes

Clinical trials showed the injectable drug, which will be sold under the name Tzield, delayed the start of insulin-dependent diabetes by more than 2 years, the FDA said.

FDA approves first drug that can delay Type 1 diabetes

The drug will cost nearly $200,000 for the 2-week treatment.

FDA approves first drug to delay onset of Type 1 diabetes

The Food and Drug Administration approved a new drug on Thursday that may postpone the onset of Type 1 diabetes, becoming the first of its kind to delay the chronic condition.